RevOpsis Therapeutics
RevOpsis Therapeutics is a biopharmaceutical company focused on developing and commercializing treatments for chronic multifactorial diseases. They utilize their proprietary Rev-Mod Platform to create multispecific biologics, with their lead candidate, RO-104, targeting neovascular age-related macular degeneration (nAMD). The company aims to improve visual outcomes and extend disease remission for patients.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: $16.5M
Date: 25-Apr-2024
Investors: a leading contract development and manufacturing organization (CDMO) with global commercial drug supply capabilities, an ophthalmic drug and device development firm, and various private and angel investors, including several leading retina specialists
Markets: Biotechnology, Pharmaceuticals, Ophthalmology
HQ: Springfield, Illinois, United States
Founded: 2018
Website: https://www.revopsis.com/
LinkedIn: https://www.linkedin.com/company/revopsis
Crunchbase: https://www.crunchbase.com/organization/revopsis-therapeutics
Leave a Comment
Comments
No comments yet.